{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:22:46Z","timestamp":1792873366013,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":5425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1111\/j.1538-7836.2008.02863.x","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T11:29:41Z","timestamp":1239794981000},"page":"346-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor"],"prefix":"10.1016","volume":"6","author":[{"given":"H.A.A.M.","family":"VAN VLIET","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"BERTINA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.A.","family":"DAHM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"ROSENDAAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"ROSING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"MORTEN SANDSET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"HELMERHORST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0010","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1538-7836.2003.00264.x","article-title":"Estrogens, progestogens and thrombosis","volume":"1","author":"Rosendaal","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0025","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0030","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"De Visser","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0050","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc-Gelas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0055","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"Van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0060","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1538-7836.2005.01430.x","article-title":"Determinants of the APTT- and ETP-based APC sensitivity tests","volume":"3","author":"De Visser","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hoibraaten","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0037-1615886","article-title":"Molecular risk factors for thrombosis","volume":"82","author":"Bertina","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0075","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood.V85.7.1815.bloodjournal8571815","article-title":"Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent anticoagulant function of protein S in plasma","volume":"85","author":"Van\u2019t Veer","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0080","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1073\/pnas.91.7.2728","article-title":"Protein S binds to and inhibits factor Xa","volume":"91","author":"Heeb","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0085","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0090","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM198412133112401","article-title":"Recurrent venous thromboembolism in patients with a partial deficiency of protein S","volume":"311","author":"Comp","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0095","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","article-title":"Plasma protein S deficiency in familial thrombotic disease","volume":"64","author":"Schwarz","year":"1984","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1642658","article-title":"Tissue factor pathway inhibitor","volume":"74","author":"Broze","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0105","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2002-10-3188","article-title":"Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis","volume":"101","author":"Dahm","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0110","series-title":"Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use","year":"1996"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0049-3848(99)00183-8","article-title":"A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1","volume":"97","author":"Bendz","year":"2000","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0125","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood.V85.10.2756.bloodjournal85102756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)","volume":"85","author":"Koster","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0130","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0037-1615062","article-title":"A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen","volume":"79","author":"Giri","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.contraception.2005.09.015","article-title":"A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol","volume":"73","author":"Kluft","year":"2006","journal-title":"Contraception"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X","article-title":"Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives","volume":"60","author":"Harris","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0038-1657571","article-title":"Tissue factor pathway inhibitor: clinical deficiency states","volume":"78","author":"Sandset","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.02863.x_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2261-6-40","article-title":"Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1","volume":"6","author":"Dahm","year":"2006","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.02863.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622129661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622129661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.02863.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:44:15Z","timestamp":1761533055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622129661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1538783622129661"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02863.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02863.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}